__NUXT_JSONP__("/drugs/Yttrium_Y-90_Clivatuzumab_Tetraxetan", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"943976-23-6",chebiId:"",chemicalFormula:"C16H25N5O7.Y",definition:"A radioimmunoconjugate comprised of the humanized monoclonal antibody clivatuzumab, directed against the pancreatic cancer antigen MUC1, that is conjugated to the chelating agent tetraxetan and radiolabeled with the beta-emitting radioisotope Yttrium Y 90. Yttrium Y 90 clivatuzumab tetraxetan binds to tumor cells expressing MUC1 antigen, thereby selectively delivering a cytotoxic dose of beta radiation.",fdaUniiCode:"2L271110ED",identifier:"C48429",preferredName:b,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129819","C1511"],synonyms:["90Y-hPAM4","IMMU-107","YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN","Yttrium (90Y) Clivatuzumab Tetraxetan","Yttrium Y 90 Clivatuzumab Tetraxetan","Yttrium Y 90 DOTA Monoclonal Antibody HuPAM4",b,"hPAM4-Cide","hPAM4-DOTA","yttrium Y 90 DOTA monoclonal antibody HuPAM4"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FYttrium_Y-90_Clivatuzumab_Tetraxetan",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Yttrium_Y-90_Clivatuzumab_Tetraxetan","Yttrium Y-90 Clivatuzumab Tetraxetan","2021-10-30T13:40:15.583Z")));